Âé¶¹´«Ã½Ó³»­

Âé¶¹´«Ã½Ó³»­

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Association Between Transthoracic Echocardiogram Parameters and White Matter Hyperintensities
Cerebrovascular Disease and Interventional Neurology
Cerebrovascular Disease and Interventional Neurology Posters (7:00 AM-5:00 PM)
134

Identify abnormal cardiac chamber size and hemodynamic parameters on transthoracic echocardiogram (TTE) as predictors of advancing cerebral small vessel disease (CSVD) on brain magnetic resonance imaging (MRI).

White matter hyperintensities (WMH) are a radiographic marker of CSVD. Alterations in cardiac structure and function have been hypothesized to be involved in the pathogenesis of WMH, although prior results have been inconsistent. We performed a cross sectional analysis of the association between cardiac measurements on TTE and WMH on MRI.

A retrospective chart review of adults with a brain MRI and a 2-dimensional TTE was performed. WMH measured by the Fazekas score served as the primary outcome. We fit multivariate ordinal logistic regression models to the Fazekas score with the individual predictors of the TTE measurements and adjusted for potential confounders.

132 individuals were included. Cardiac functional markers, such as tricuspid annular plane systolic excursion were not significant. Cardiac structural markers included apical 4-chamber end-systole right atrial area, diastolic right ventricular base internal diameter (RVID) and apical 4-chamber end-systole left atrial area (LAA). RVID (OR 0.46, 95% CI 0.24 to 0.89, p = 0.020) and LAA (OR 0.94, 95% CI 0.88 to 1.00, p = 0.041) were identified as being predictors, although the direction of the association suggested that normal values resulted in more WMH. Analysis of isolated DWM or PVWM Fazekas scores were not significant predictors of cardiac structure or function.

In our study, we found that normal LAA and RVID values were associated with an increased degree of WMH on MRI. This finding may be possible due to increased central venous pressure prior to cardiac remodeling or due to differences in imaging modalities. Several limitations are noted including subjectivity in interpreting TTE data. Future studies are needed for more robust objective comparison between cardiac chamber sizes and development of WMH.

Authors/Disclosures
Kayla Navarro
PRESENTER
Miss Navarro has nothing to disclose.
Ka-Ho Wong (U of U Neurology Clinic) The institution of Mr. Wong has received research support from The Sumaira Foundation . The institution of Mr. Wong has received research support from The Siegel Rare Neuroimmune Association.
No disclosure on file
Adam De Havenon, MD, FÂé¶¹´«Ã½Ó³»­ (Yale University) Dr. De Havenon has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novo Nordisk. Dr. De Havenon has or had stock in Certus.Dr. De Havenon has or had stock in TitinKM. The institution of Dr. De Havenon has received research support from NIH/NINDS. Dr. De Havenon has received publishing royalties from a publication relating to health care.
Eric Goldstein, MD (Brown University Warren Alpert School of Medicine) Dr. Goldstein has nothing to disclose.